COVID-19 patients can be categorized into three groups
Study identifies possible COVID-19 drugs—including several that are FDA-approved
2 April 2021Age dependent associations of risk factors with heart failure: pooled population based cohort study
3 April 2021COVID-19 patients can be categorized into three groups
In a new study, researchers identify three clinical COVID-19 phenotypes, reflecting patient populations with different comorbidities, complications and clinical outcomes. The three phenotypes are described in a paper published this week in the open-access journal PLOS ONE 1st authors Elizabeth Lusczek and Nicholas Ingraham of University of Minnesota Medical School, US, and colleagues.
